ARCHIVES

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

Cancer Webmasters Seek to Develop Tools for Greater Use of NCI Cancer Information

May 5, 2000

Court Agreement Clears The Way For Human Gene Transplant Study

May 26, 1989

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988

Publisher Receives Six Figures Settlement In Copyright Case

May 11, 1990